Applied DNA Sciences, Inc.
APDNNASDAQHealthcare
$5.62
+$1.35(+31.62%)
Market Cap$7257454
P/E Ratio—
52W High$319.95
52W Low$2.13
Applied DNA Sciences, Inc. (APDN) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · APDN · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-09 | 2024-09 | 2023-09 | 2022-09 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.14M | $3.43M | $13.37M | $18.17M | $9.03M |
| Cost of Revenue | $1.30M | $2.41M | $7.83M | $13.12M | $4.10M |
| Gross Profit | $0.84M | $1.02M | $5.53M | $5.05M | $4.93M |
| Gross Margin %(computed) | 39.26% | 29.63% | 41.39% | 27.82% | 54.59% |
| Operating Expenses | |||||
| R&D Expenses | $6.02M | $3.59M | $3.74M | $3.93M | $3.77M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $16.89M | $15.04M | $16.49M | $19.02M | $17.22M |
| Operating Income | ($16.05M) | ($14.02M) | ($10.95M) | ($13.97M) | ($12.29M) |
| Operating Margin %(computed) | -750.92% | -408.72% | -81.94% | -76.89% | -136.16% |
| Interest Income | $0.19M | $0.18M | $0.08M | $0.01M | $0.01M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($15.64M) | ($7.09M) | ($10.02M) | ($8.27M) | ($14.28M) |
| Income Tax Expense | $0.68M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($69.49M) | ($6.99M) | ($9.95M) | ($8.38M) | ($16.03M) |
| Net Margin %(computed) | — | -203.78% | -74.41% | -46.11% | -177.56% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-134.23 | $-1.82 | $-15.21 | $-18.68 | $-46.35 |
| Wtd Avg Shares | 0.52M | 3.97M | 0.65M | 0.45M | 0.35M |
| EBITDA | ($16.05M) | ($13.33M) | ($9.59M) | ($12.68M) | ($11.68M) |
| EBITDA Margin %(computed) | -750.92% | -388.42% | -71.75% | -69.79% | -129.41% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Applied DNA Sciences, Inc. data
About Applied DNA Sciences, Inc. (APDN) Income Statement
Applied DNA Sciences, Inc. (APDN) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, APDN reported revenue of $0.00B, gross profit of $0.00B (gross margin 39.26%), and net income of ($0.07B) — a net profit margin of -3251.74%.
Frequently asked questions
APDN · 4 questionsApplied DNA Sciences, Inc. (APDN) reported revenue of $0.00B for 2025, down 37.7% year-over-year.
APDN revenueAPDN salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09